华峰化学
(002064)
| 流通市值：388.96亿 | | | 总市值：390.06亿 |
| 流通股本：49.49亿 | | | 总股本：49.63亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 12,136,602,677.19 | 6,313,831,888.08 | 26,931,407,159.39 | 20,372,576,369.44 |
| 营业收入 | 12,136,602,677.19 | 6,313,831,888.08 | 26,931,407,159.39 | 20,372,576,369.44 |
| 二、营业总成本 | 11,210,109,219.47 | 5,837,290,678.9 | 24,617,261,303.53 | 18,309,593,055.4 |
| 营业成本 | 10,465,131,079.31 | 5,463,603,521.28 | 23,205,470,168.77 | 17,195,152,458.59 |
| 税金及附加 | 49,616,651.53 | 25,358,316.3 | 118,398,461.81 | 74,433,773.93 |
| 销售费用 | 113,669,898.03 | 58,977,063.29 | 212,498,617.08 | 144,762,149.78 |
| 管理费用 | 189,753,531.73 | 94,161,550.24 | 407,658,727.43 | 296,183,250.14 |
| 研发费用 | 466,284,545.88 | 210,281,196.97 | 809,381,873.78 | 721,240,163.35 |
| 财务费用 | -74,346,487.01 | -15,090,969.18 | -136,146,545.34 | -122,178,740.39 |
| 其中:利息费用 | 32,462,471.65 | 16,940,802.71 | 118,371,370.25 | 102,405,016.92 |
| 其中:利息收入 | 59,228,276.68 | 31,039,978.19 | 262,001,210.32 | 238,726,900.84 |
| 加:公允价值变动收益 | 9,531,767.21 | 11,467,244.73 | 2,335,651.28 | 5,446,492.74 |
| 加:投资收益 | 93,909,015.96 | 34,340,095.93 | 127,444,625.24 | 89,642,266.97 |
| 净敞口套期收益 | 0 | - | - | - |
| 汇兑收益 | 0 | - | - | - |
| 资产处置收益 | 7,390,514.92 | 7,721,058.5 | 2,598,510.09 | 2,120,129.25 |
| 资产减值损失(新) | -22,697,657.8 | - | -180,558,121.88 | -2,581,801.12 |
| 信用减值损失(新) | -47,937,809.8 | -36,357,621.71 | -3,016,757.94 | -32,084,419.24 |
| 其他收益 | 141,214,681.81 | 84,055,170.62 | 300,474,603.73 | 201,802,368.13 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,107,903,970.02 | 577,767,157.25 | 2,563,424,366.38 | 2,327,328,350.77 |
| 加:营业外收入 | 6,039,057.45 | 1,716,507.43 | 23,779,431.38 | 4,159,383.61 |
| 减:营业外支出 | 28,332,788.3 | 13,192,803.57 | 73,609,659.71 | 44,226,863.01 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,085,610,239.17 | 566,290,861.11 | 2,513,594,138.05 | 2,287,260,871.37 |
| 减:所得税费用 | 96,818,962.26 | 60,363,569.3 | 286,760,118.7 | 267,702,640.24 |
| 六、净利润 | 988,791,276.91 | 505,927,291.81 | 2,226,834,019.35 | 2,019,558,231.13 |
| 持续经营净利润 | 988,791,276.91 | 505,927,291.81 | 2,226,834,019.35 | 2,019,558,231.13 |
| 归属于母公司股东的净利润 | 983,310,926.88 | 504,316,364.85 | 2,219,955,309.42 | 2,014,617,736.84 |
| 少数股东损益 | 5,480,350.03 | 1,610,926.96 | 6,878,709.93 | 4,940,494.29 |
| (一)基本每股收益 | 0.2 | 0.1 | 0.45 | 0.41 |
| (二)稀释每股收益 | 0.2 | 0.1 | 0.45 | 0.41 |
| 八、其他综合收益 | 21,644,534.46 | 7,609,112.28 | 56,335,506.66 | 6,999,663.06 |
| 归属于母公司股东的其他综合收益 | 21,655,294.88 | 7,377,915.93 | 56,560,862.54 | 6,980,555.81 |
| 九、综合收益总额 | 1,010,435,811.37 | 513,536,404.09 | 2,283,169,526.01 | 2,026,557,894.19 |
| 归属于母公司股东的综合收益总额 | 1,004,966,221.76 | 511,694,280.78 | 2,276,516,171.96 | 2,021,598,292.65 |
| 归属于少数股东的综合收益总额 | 5,469,589.61 | 1,842,123.31 | 6,653,354.05 | 4,959,601.54 |
| 公告日期 | 2025-08-12 | 2025-04-26 | 2025-03-29 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |